Molecule in urine ‘could be the first to reveal early-stage Alzheimer’s disease’ The findings suggest a simple urine test could be used to identify people who are in the early stages of the disease. The Independent UK · Nov 30, 2022
New Alzheimer’s drug hailed as 'beginning of the end' in quest for treatment Clinical results suggest that the disease progression can by slowed by 27% Wales Online · Nov 30, 2022
New Alzheimer’s drug hailed as ‘beginning of the end’ in search for treatment Lecanemab was found to slow decline in patients’ memory and thinking. The Independent UK · Nov 30, 2022
Another Alzheimer’s drug fails in late-stage trials – what now? Around 55 million people, globally, have dementia – the most common type being Alzheimer’s disease. Unfortunately, there is no cure for the memory-robbing disease. But a lot of hope was pinned on an experimental drug called gantenerumab. The Conversation · Nov 22, 2022
How likely is Chris Hemsworth to get Alzheimer’s disease and what are its signs? The actor told Vanity Fair the discovery he is at high risk is his ‘biggest fear’ but said: ‘It’s not like I’ve been handed my resignation’ Evening Standard · Nov 22, 2022
Chris Hemsworth reveals he inherits Alzheimer's gene from both parents. What is the ApoE4 gene and what does it mean for his career? After two decades of acting, Chris Hemsworth revealed he will take a break from his career, after learning he has a much higher-than-average chance of developing Alzheimer's disease. ABC News · Nov 21, 2022
Chris Hemsworth learns he has a predisposition to Alzheimer's disease; may take break from acting Hollywood actor Chris Hemsworth, who recently featured in the docuseries 'Limitless', has revealed that he has a genetic predisposition to Alzheimer's disease, and therefore may be taking a break from acting. The Times of India · Nov 20, 2022
My work investigating the links between viruses and Alzheimer’s disease was dismissed for years – but now the evidence is building This article is part of the Insights Uncharted Brain series. There are many competing theories about what causes Alzheimer’s disease. Here, Ruth Itzhaki reflects on a career dedicated to one of the more controversial lines of research. The Conversation · Nov 15, 2022
Disappointment after potential Alzheimer’s drug fails Roche trial Swiss pharmaceutical firm carried out two identical phase 3 trials of gantenerumab, with about 1,000 volunteers in each The Guardian - UK · Nov 14, 2022
Consumer Health: Can music help someone with Alzheimer's disease? Alzheimer's disease is a progressive disorder that causes brain cells to waste away and die. Alzheimer's disease is the most common cause of dementia, which is a term used to describe a group of symptoms that affect memory, thinking and social abilities severely enough to interfere with daily function. Tribune News Service · Nov 9, 2022
Does picking your nose really increase your risk of dementia? Research Checks interrogate newly published studies and how they’re reported in the media. The analysis is undertaken by one or more academics not involved with the study, and reviewed by another, to make sure it’s accurate. The Conversation · Nov 3, 2022
IGC Q2 2023 Revenue Grows 261%, THC Based Drug For Alzheimer's Entering Phase 2 Trials India Globalization Capital, Inc. (AMEX:IGC) reported its second fiscal quarter 2023 financial results, revealing revenue of $202,000, a 261% increase compared to $56,000 in the same quarter of 2022. Benzinga · Nov 2, 2022
Alzheimer's disease risk increased by picking your nose and plucking hair, warns study Some habits are seemingly innocent, but some are not only disgusting but could also cause you to unwittingly raise your risk of certain diseases. Case in point: picking your nose Daily Mirror · Nov 1, 2022
Alzheimer's may not be a brain disease A group of neuroscience researchers think Alzheimer's is an autoimmune condition — could this lead to a cure? Salon · Oct 15, 2022
The Conversation · Oct 14, 2022 Alzheimer's disease: surprising new theory about what might cause it In 1906, Alois Alzheimer, a psychiatrist and neuroanatomist, reported “a peculiar severe disease process of the cerebral cortex” to a gathering of psychiatrists in Tübingen, Germany. The case was a 50-year-old woman who suffered from memory loss, delusions, hallucinations, aggression and confusion – all of which worsened until her untimely…
Wales Online · Oct 8, 2022 New Alzheimer's drug that slows cognitive decline could be available next year People who are prescribed the drug will need regular MRI scans to check for brain swelling or bleeding
The Conversation · Oct 4, 2022 New Alzheimer's drug slows cognitive decline – and may be available as early as next year Lecanemab is the first drug to help improve the symptoms of Alzheimer’s by slowing the disease. These are very promising results, although the only data we have at the moment is from the drugmaker’s press release.
Tribune News Service · Oct 4, 2022 Mayo Clinic expert offers perspective on experimental Alzheimer's disease drug According to drugmakers Eisai and Biogen, a Phase 3 clinical study on a potential new Alzheimer's disease drug shows promise. The study findings show that the drug, lecanemab, reduced clinical decline of people with Alzheimer's disease by 27% compared with a placebo after 18 months of treatment.
Tribune News Service · Oct 3, 2022 Texas researchers receive $149 million for large study of Alzheimer’s in racial, ethnic groups FORT WORTH, Texas — The National Institutes of Health is giving $149 million to researchers at the University of North Texas Health Science Center to pay for researchers to study the biology of Alzheimer’s disease in multiple racial and ethnic groups.
Daily Record · Oct 3, 2022 Alzheimer's risk increased by 80% in over 65s who have had Covid, claims study Experts are still unclear as to whether Covid can trigger the onset of Alzheimer's or speed its development.
Evening Standard · Oct 3, 2022 Over-65s twice as likely to develop Alzheimer’s within a year of Covid infection, according to study Researchers from the Case Western Reserve University in Cleveland, Ohio analysed the electronic health records of 6.2 million adults
Liverpool Echo · Oct 3, 2022 Covid warning to everyone aged 66 and above New research has found over 65s who contract covid increase their risk of getting Alzheimer's
Wales Online · Oct 3, 2022 Having had Covid can increase risk of Alzheimer's by 80% for some people Researchers aren't certain whether COVID-19 triggers new development of Alzheimer’s disease or accelerates its emergence
The Independent UK · Oct 2, 2022 Over-65s who had Covid are 80 per cent more likely to develop Alzheimer’s, study reveals It is unclear whether coronavirus triggers new development of the disease or accelerates its emergence
The New Daily · Oct 1, 2022 ‘Historic moment’: Drug slows cognitive decline in Alzheimer’s It's being widely reported that an experimental drug has slowed the cognitive decline and brain damage in Alzheimer's patients.